Aadi Bioscience CEO Stephen Hoffman's 2019 pay jumps 45% to $2.1M
Aadi Bioscience reports 2019 executive compensation
By ExecPay News
Published: April 27, 2020
Aadi Bioscience reported fiscal year 2019 executive compensation information on April 27, 2020.
In 2019, five executives at Aadi Bioscience received on average a compensation package of $1.2M, a 43% increase compared to previous year.
Average pay of disclosed executives at Aadi Bioscience
Stephen Hoffman, Chief Executive Officer, received $2.1M in total, which increased by 45% compared to 2018. 56% of Hoffman's compensation, or $1.2M, was in option awards. Hoffman also received $394K in salary and $535K in other compensation.
Michael Rogers, Former Chief Financial and Business Officer, received a compensation package of $1.6M, which increased by 78% compared to previous year. 50% of the compensation package, or $800K, was in option awards.
Joseph Gardner, Founder, earned $1.1M in 2019, a 12% increase compared to previous year.
Kevin Peters, Chief Medical and Scientific Officer, received $948K in 2019, which increases by 29% compared to 2018.
Regina Marek, VP Finance, Principal Financial and Accounting Officer, earned $486K in 2019, a 61% increase compared to previous year.
Related executives
Joseph Gardner
Aadi Bioscience
Former President and Principal Executive Officer
Kevin Peters
Aadi Bioscience
Chief Medical and Scientific Officer
Regina Marek
Aadi Bioscience
VP Finance, Principal Financial and Accounting Officer
Stephen Hoffman
Aadi Bioscience
Chief Executive Officer
Michael Rogers
Aadi Bioscience
Former Chief Financial and Business Officer
You may also like
Source: SEC filing on April 27, 2020.